Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control
2011 ◽
Vol 12
(10)
◽
pp. 1481-1489
◽
2018 ◽
Vol 34
(10)
◽
pp. 1713-1715
2008 ◽
Vol 52
(8)
◽
pp. 626-632
◽
2018 ◽
Vol 7
(18)
◽
2010 ◽
Vol 4
(2)
◽
pp. 126-132
◽
2004 ◽
Vol 43
(5)
◽
pp. A418
2010 ◽
Vol 21
(3)
◽
pp. 182-188
◽
2010 ◽
Vol 55
(10)
◽
pp. A136.E1274